Table 1.
Authors | Panel of markers | Groups | n (sample number) | Sensitivity (%) | Specificity (%) | Diagnostic accuracy (%) |
---|---|---|---|---|---|---|
Stokowy et al. 2016 | miR-484, miR-184b-3p |
mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas | 44 | 89 | 87 | na |
Paskas et al. 2015 | BRAF V600E, miR-221, miR-222, galectin-3 |
benign vs. malignant thyroid nodule | 120 | 73.5 | 89.8 | 75.7 |
Panebianco et al. 2015 | miR-146b, miR-222, KIT, TC1 |
benign vs. malignant thyroid nodule | 118 | 92.3 | 94.7 | 96 |
Shen et al. 2012 | miR-146b, miR-221, miR-187, miR-30d |
benign vs. malignant thyroid nodule | 68 | 88.9 | 78.3 | 85.3 |
Keutgen et al. 2012 | miR-328, miR-222, miR-21, miR-197 |
benign vs. malignant thyroid lesions | 72 | 100 | 86 | 90 |
Mazeh et al. 2012 | miR-21, miR-31, miR-146b, miR-187, miR-221, miR-222 |
benign vs. malignant thyroid nodule | 11 | 88 | 100 | 90 |